Exploring the Association Between Gender Affirmation and PrEP use Among Transgender Women in New York City
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature..
Black and Hispanic/Latina transgender women are inequitably impacted by HIV; yet gaps in PrEP use exist. Among a sample of mostly Black and Hispanic/Latina transgender women in New York City, we aim to examine whether PrEP use was associated with gender affirmation and the use of gender-affirming health services. We found that PrEP use was more prevalent among those who used hormone therapy and those who had a provider they were comfortable speaking to about gender-related issues. In separate models, these associations were attenuated when adjusting for race/ethnicity, with those who use hormones being marginally more likely to report PrEP use and with Hispanic/Latina transgender women being more likely to have used PrEP, compared to Black transgender women. We found evidence of a potential association between medical gender affirmation and PrEP use. More research is needed to explore the social and structural contexts that are influenced by race/ethnicity that may serve to prevent PrEP uptake.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
---|---|
Enthalten in: |
AIDS and behavior - 27(2023), 5 vom: 27. Mai, Seite 1523-1530 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rivera, Alexis V [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anti-HIV Agents |
---|
Anmerkungen: |
Date Completed 17.05.2023 Date Revised 19.05.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s10461-022-03944-7 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM350856486 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM350856486 | ||
003 | DE-627 | ||
005 | 20231226045933.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s10461-022-03944-7 |2 doi | |
028 | 5 | 2 | |a pubmed24n1169.xml |
035 | |a (DE-627)NLM350856486 | ||
035 | |a (NLM)36574185 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Rivera, Alexis V |e verfasserin |4 aut | |
245 | 1 | 0 | |a Exploring the Association Between Gender Affirmation and PrEP use Among Transgender Women in New York City |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.05.2023 | ||
500 | |a Date Revised 19.05.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. | ||
520 | |a Black and Hispanic/Latina transgender women are inequitably impacted by HIV; yet gaps in PrEP use exist. Among a sample of mostly Black and Hispanic/Latina transgender women in New York City, we aim to examine whether PrEP use was associated with gender affirmation and the use of gender-affirming health services. We found that PrEP use was more prevalent among those who used hormone therapy and those who had a provider they were comfortable speaking to about gender-related issues. In separate models, these associations were attenuated when adjusting for race/ethnicity, with those who use hormones being marginally more likely to report PrEP use and with Hispanic/Latina transgender women being more likely to have used PrEP, compared to Black transgender women. We found evidence of a potential association between medical gender affirmation and PrEP use. More research is needed to explore the social and structural contexts that are influenced by race/ethnicity that may serve to prevent PrEP uptake | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Gender affirmation | |
650 | 4 | |a PrEP | |
650 | 4 | |a Race/ethnicity | |
650 | 4 | |a Transgender women | |
650 | 7 | |a Anti-HIV Agents |2 NLM | |
700 | 1 | |a Lopez, Jasmine M |e verfasserin |4 aut | |
700 | 1 | |a Braunstein, Sarah L |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t AIDS and behavior |d 1997 |g 27(2023), 5 vom: 27. Mai, Seite 1523-1530 |w (DE-627)NLM09651440X |x 1573-3254 |7 nnns |
773 | 1 | 8 | |g volume:27 |g year:2023 |g number:5 |g day:27 |g month:05 |g pages:1523-1530 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10461-022-03944-7 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 27 |j 2023 |e 5 |b 27 |c 05 |h 1523-1530 |